Point72 Hong Kong LTD Mckesson Corp Transaction History

Point72 Hong Kong LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$473.42 - $539.26 $4.96 Million - $5.65 Million	10,477 New	10,477 $5.62 Million
Q3 2022 Nov 14, 2022	BUY	$321.25 - $373.84 $30,840 - $35,888	96 New	96 $33,000
Q3 2022 Nov 14, 2022	BUY	$321.25 - $373.84 $30,840 - $35,888	96 New	96 $33,000
Q4 2021 Feb 14, 2022	BUY	$198.21 - $248.9 $2.31 Million - $2.89 Million	11,631 Added 1392.93%	12,466 $3.1 Million
Q3 2021 Nov 15, 2021	SELL	$188.42 - $208.66 $4.52 Million - $5 Million	-23,970 Reduced 96.63%	835 $166,000
Q2 2021 Aug 16, 2021	BUY	$184.89 - $202.68 $3.81 Million - $4.17 Million	20,595 Added 489.19%	24,805 $4.74 Million
Q1 2021 May 17, 2021	SELL	$169.52 - $196.53 $269,028 - $311,893	-1,587 Reduced 27.38%	4,210 $821,000
Q4 2020 Feb 16, 2021	SELL	$143.79 - $183.66 $282,978 - $361,442	-1,968 Reduced 25.34%	5,797 $1.01 Million
Q3 2020 Nov 16, 2020	SELL	$140.89 - $159.9 $1.3 Million - $1.48 Million	-9,244 Reduced 54.35%	7,765 $1.16 Million
Q2 2020 Aug 14, 2020	BUY	$125.49 - $164.68 $2.13 Million - $2.8 Million	17,009 New	17,009 $2.61 Million
Q4 2018 Feb 14, 2019	SELL	$108.23 - $136.84 $423,828 - $535,865	-3,916 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$123.14 - $138.52 $482,216 - $542,444	3,916 New	3,916 $519,000
Q2 2018 Aug 14, 2018	SELL	$133.4 - $158.13 $96,314 - $114,169	-722 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$138.75 - $176.72 $87,967 - $112,040	-634 Reduced 46.76%	722 $102,000
Q4 2017 Feb 14, 2018	BUY	$135.02 - $162.6 $183,087 - $220,485	1,356	1,356 $211,000

1,713

112M

871K

900K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $75.6B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.